Austin Private Wealth LLC Acquires 1,184 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Austin Private Wealth LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 96.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,415 shares of the healthcare conglomerate’s stock after purchasing an additional 1,184 shares during the quarter. Austin Private Wealth LLC’s holdings in UnitedHealth Group were worth $1,412,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Crestwood Advisors Group LLC increased its stake in shares of UnitedHealth Group by 27.3% during the 3rd quarter. Crestwood Advisors Group LLC now owns 3,878 shares of the healthcare conglomerate’s stock worth $2,267,000 after purchasing an additional 831 shares during the last quarter. Ameritas Advisory Services LLC lifted its position in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Ameritas Advisory Services LLC now owns 9,881 shares of the healthcare conglomerate’s stock valued at $5,777,000 after buying an additional 83 shares during the last quarter. Arthur M. Cohen & Associates LLC raised its stake in UnitedHealth Group by 4.6% in the 3rd quarter. Arthur M. Cohen & Associates LLC now owns 2,730 shares of the healthcare conglomerate’s stock valued at $1,592,000 after acquiring an additional 120 shares during the period. Hanlon Investment Management Inc. boosted its position in UnitedHealth Group by 50.6% during the third quarter. Hanlon Investment Management Inc. now owns 592 shares of the healthcare conglomerate’s stock worth $346,000 after purchasing an additional 199 shares during the period. Finally, Pittenger & Anderson Inc. lifted its stake in shares of UnitedHealth Group by 1.5% during the 3rd quarter. Pittenger & Anderson Inc. now owns 42,498 shares of the healthcare conglomerate’s stock valued at $24,848,000 after buying an additional 628 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on UNH shares. Wells Fargo & Company lifted their target price on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Stephens dropped their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Trading Up 0.9 %

NYSE:UNH traded up $5.22 during trading hours on Tuesday, hitting $562.99. The company had a trading volume of 317,993 shares, compared to its average volume of 3,876,738. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a market capitalization of $519.88 billion, a PE ratio of 36.24, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. The stock has a 50-day moving average price of $581.37 and a 200 day moving average price of $542.90.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.56 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.49%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.